1. Home
  2. Programs
  3. On the Frontlines of Metastatic Breast Cancer

Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Related
  • Overview

    When making treatment decisions for patients with metastatic breast cancer, acknowledging both efficacy and tolerability is key. Dr. Paolo Tarantino joins the program to explain how patient-specific factors and timely treatment changes can help optimize outcomes. Dr. Tarantino is a medical oncologist and Clinical Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute and Harvard Medical School.

Recommended
Details
Presenters
Related
  • Overview

    When making treatment decisions for patients with metastatic breast cancer, acknowledging both efficacy and tolerability is key. Dr. Paolo Tarantino joins the program to explain how patient-specific factors and timely treatment changes can help optimize outcomes. Dr. Tarantino is a medical oncologist and Clinical Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute and Harvard Medical School.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free